Tirapazamine

Modify Date: 2024-01-02 16:18:14

Tirapazamine Structure
Tirapazamine structure
Common Name Tirapazamine
CAS Number 27314-97-2 Molecular Weight 178.148
Density 1.7±0.1 g/cm3 Boiling Point 493.6±28.0 °C at 760 mmHg
Molecular Formula C7H6N4O2 Melting Point 220ºC
MSDS Chinese USA Flash Point 252.3±24.0 °C
Symbol GHS07
GHS07
Signal Word Warning

 Use of Tirapazamine


Tirapazamine is an anticancer agent that shows selective cytotoxicity for hypoxic cells in solid tumors, thereby inducing single-and double-strand breaks in DNA, base damage, and cell death.

 Names

Name tirapazamine
Synonym More Synonyms

 Tirapazamine Biological Activity

Description Tirapazamine is an anticancer agent that shows selective cytotoxicity for hypoxic cells in solid tumors, thereby inducing single-and double-strand breaks in DNA, base damage, and cell death.
Related Catalog
References

[1]. Cai TY, et al. Tirapazamine sensitizes hepatocellular carcinoma cells to topoisomerase I inhibitors via cooperative modulation of hypoxia-inducible factor-1α. Mol Cancer Ther. 2014 Mar;13(3):630-42.

[2]. Sliwinska J, et al. Tirapazamine-doxorubicin interaction referring to heart oxidative stress and Ca2? balance protein levels. Oxid Med Cell Longev. 2012;2012:890826.

 Chemical & Physical Properties

Density 1.7±0.1 g/cm3
Boiling Point 493.6±28.0 °C at 760 mmHg
Melting Point 220ºC
Molecular Formula C7H6N4O2
Molecular Weight 178.148
Flash Point 252.3±24.0 °C
Exact Mass 178.049072
PSA 89.83000
LogP -0.31
Vapour Pressure 0.0±1.3 mmHg at 25°C
Index of Refraction 1.777

 Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
DM0671500
CHEMICAL NAME :
1,2,4-Benzotriazine, 3-amino-, 1,4-dioxide
CAS REGISTRY NUMBER :
27314-97-2
BEILSTEIN REFERENCE NO. :
0179322
LAST UPDATED :
199712
DATA ITEMS CITED :
8
MOLECULAR FORMULA :
C7-H6-N4-O2
MOLECULAR WEIGHT :
178.17

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
59390 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD - Lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
>36 mg/kg
TOXIC EFFECTS :
Kidney, Ureter, Bladder - changes in tubules (including acute renal failure, acute tubular necrosis) Endocrine - other changes Blood - changes in bone marrow (not otherwise specified)
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
89 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
101 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity) Skin and Appendages - hair Nutritional and Gross Metabolic - weight loss or decreased weight gain
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
19 mg/kg/2W-C
TOXIC EFFECTS :
Related to Chronic Data - death

MUTATION DATA

TYPE OF TEST :
Unscheduled DNA synthesis
TEST SYSTEM :
Rodent - rat Mammary gland
DOSE/DURATION :
500 umol/L
REFERENCE :
CRNGDP Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- Volume(issue)/page/year: 11,1407,1990

 Safety Information

Symbol GHS07
GHS07
Signal Word Warning
Hazard Statements H315-H319-H335
Precautionary Statements P261-P305 + P351 + P338
Hazard Codes Xi: Irritant;
Risk Phrases 36/37/38
Safety Phrases 26-36
RIDADR NONH for all modes of transport
RTECS DM0671500

 Synthetic Route

~79%

Tirapazamine Structure

Tirapazamine

CAS#:27314-97-2

Literature: Suzuki, Hitomi; Kawakami, Takehiko Synthesis, 1997 , # 8 p. 855 - 857

~75%

Tirapazamine Structure

Tirapazamine

CAS#:27314-97-2

Literature: Gatenyo, Julia; Johnson, Kevin; Rajapakse, Anuruddha; Gates, Kent S.; Rozen, Shlomo Tetrahedron, 2012 , vol. 68, # 43 p. 8942 - 8944

~%

Tirapazamine Structure

Tirapazamine

CAS#:27314-97-2

Literature: Gatenyo, Julia; Johnson, Kevin; Rajapakse, Anuruddha; Gates, Kent S.; Rozen, Shlomo Tetrahedron, 2012 , vol. 68, # 43 p. 8942 - 8944

~0%

Tirapazamine Structure

Tirapazamine

CAS#:27314-97-2

Detail
Literature: Fuchs; Chowdhury; Barnes; Gates Journal of Organic Chemistry, 2001 , vol. 66, # 1 p. 107 - 114

~%

Tirapazamine Structure

Tirapazamine

CAS#:27314-97-2

Literature: Fuchs; Chowdhury; Barnes; Gates Journal of Organic Chemistry, 2001 , vol. 66, # 1 p. 107 - 114

~%

Tirapazamine Structure

Tirapazamine

CAS#:27314-97-2

Literature: Suzuki, Hitomi; Kawakami, Takehiko Synthesis, 1997 , # 8 p. 855 - 857

~%

Tirapazamine Structure

Tirapazamine

CAS#:27314-97-2

Literature: Robbins; Schofield Journal of the Chemical Society, 1957 , p. 3186,3191

~%

Tirapazamine Structure

Tirapazamine

CAS#:27314-97-2

Literature: Robbins; Schofield Journal of the Chemical Society, 1957 , p. 3186,3191

~%

Tirapazamine Structure

Tirapazamine

CAS#:27314-97-2

Literature: Fuchs; Chowdhury; Barnes; Gates Journal of Organic Chemistry, 2001 , vol. 66, # 1 p. 107 - 114

 Articles36

More Articles
An innovative three-dimensional gelatin foam culture system for improved study of glioblastoma stem cell behavior.

J. Biomed. Mater. Res. B. Appl. Biomater. 103(3) , 618-28, (2015)

Three-dimensional (3-D) tissue engineered constructs provide a platform for examining how the local extracellular matrix contributes to the malignancy of various cancers, including human glioblastoma ...

Tirapazamine-doxorubicin interaction referring to heart oxidative stress and Ca²⁺ balance protein levels.

Oxid. Med. Cell. Longev. 2012 , 890826, (2012)

Doxorubicin (DOX) causes long-term cardiomyopathy that is dependent on oxidative stress and contractility disorders. Tirapazamine (TP), an experimental adjuvant drug, passes the same red-ox transforma...

Exploiting tumour hypoxia and overcoming mutant p53 with tirapazamine.

Br. J. Cancer 77 Suppl 4 , 12-4, (1998)

Human solid tumours are composed of a significant proportion of hypoxic cells, i.e. cells with oxygen levels lower than those of normal tissues. Tumour hypoxic cells have been shown to have a negative...

 Synonyms

4-hydroxy-1-oxido-1,2,4-benzotriazin-1-ium-3-imine
1,2,4-Benzotriazin-3-amine, 1,4-dioxide
3-Amino-1,2,4-benzotriazine 1,4-Dioxide
1,4-Dioxido-1,2,4-benzotriazin-3-ylamine
SR 259075
1,2,4-Benzotriazin-3-amine 1,4-dioxide
4-Hydroxy-1-oxido-1,2,4-benzotriazin-1-ium-3-imine SR 259075 SR 4233 Tirazone Win 59075
Tirazone
Tirapazamine
3-Aminobenzo[e][1,2,4]triazine 1,4-dioxide